VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MODDModular Medical, Inc.
$4.94$10M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMODDCash Flow

Modular Medical, Inc. (MODD) Cash Flow Statement

19Y historyFree accessUpdated daily

Free cash flow deficits have accelerated to $8.4 million in 2026Q3, driven by rising capital expenditures of $1.2 million and persistent operational cash outflows.

MODD Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMMar'25Mar'24Mar'23Mar'22Mar'21Mar'20Mar'19Mar'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'08Jun'07Jun'06Jun'05Jun'04
Cash from Operations-22.25M-15.72M-13.95M-11.01M-10.26M-5.91M-4.09M-1.81M-791.13K-94.81K-10.66K000-17.49K-6.72K00-76-84
Operating CF Margin %--------------------
Operating CF Growth %-192.81%-12.67%-26.7%-7.33%-73.64%-44.3%-126.49%-128.53%-734.44%-789.15%---100%-160.45%--100%9.52%-
Net Income-26.78M-18.82M-17.47M-13.88M-18.63M-7.38M-5.32M-2.54M-659.25K-106.56K-31.08K-30.99K-22.79K-20.79K-17.49K-6.72K-6.48K-8.91K-14.29K-6.21K
Depreciation & Amortization1.56M1.06M768K152.4K117.49K181.84K35.43K14.47K1.86K00000000000
Stock-Based Compensation2.44M2.38M2.7M2.72M4.03M1.23M801.24K532.11K000000000000
Deferred Taxes000000-341.86K0000000000000
Other Non-Cash Items140K52K143K202.67K3.85M121.04K341.86K19.8K3.72K-30-220-17.49K-6.72K01.5K1.5K0
Working Capital Changes389K-392K-94K-211.82K374.99K-61.15K389.36K165.19K-133.75K11.75K20.42K30.99K22.79K20.79K17.49K6.72K6.48K7.41K12.71K6.12K
Change in Receivables00000000000000000000
Change in Inventory00000000000000000000
Change in Payables593K0458K-200.76K00530.25K0-109.75K00-1.55K1.55K0-57800000
Cash from Investing-3.88M-2.49M-1.7M-1.64M-54.76K-109.67K-260.79K-77.12K-15.33K00000000000
Capital Expenditures-3.88M-2.49M-1.7M-1.64M-54.76K-109.67K-260.79K-77.12K-15.33K00000000000
CapEx % of Revenue--------------------
Acquisitions00000000000000000000
Investments--------------------
Other Investing00000000-21300000000000
Cash from Financing22.07M22.08M21.09M7.37M17.92M4.36M923.99K4.14M4.71M1.47M10.66K000000000
Debt Issued (Net)00004.14M2.58M00000000000000
Equity Issued (Net)22.07M20.82M20.34M7.37M13.79M1.79M923.99K4.14M4.73M-14.1K0000000000
Dividends Paid00000000000000000000
Share Repurchases000000000-14.1K0000000000
Other Financing5K1.25M742K-347000-516-20.74K1.48M10.66K000000000
Net Change in Cash-4.05M3.86M5.43M-5.28M7.61M-1.65M-3.43M2.26M3.9M1.37M0000-17.49K-6.72K00-76-84
Free Cash Flow-26.12M-18.21M-15.65M-12.65M-10.31M-6.02M-4.36M-1.89M-806.46K-94.81K-10.66K000-17.49K-6.72K00-76-84
FCF Margin %--------------------
FCF Growth %-54.2%-16.36%-23.74%-22.64%-71.38%-38.17%-131.06%-133.74%-750.61%-789.15%---100%-160.45%--100%9.52%-
FCF per Share-11.89-14.76-20.98-34.88-45.45-29.07-21.94-10.23-5.44-2.44-0.77----1.26-0.48---0.01-0.02
FCF Conversion (FCF/Net Income)0.98x0.84x0.80x0.79x0.55x0.80x0.77x0.71x1.20x0.89x0.34x---1.00x1.00x--0.01x0.01x
Interest Paid0000262K000000000000000
Taxes Paid02K2K2K1.6K1.6K1.6K1.59K1.6K00000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and regulatory dependency

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Persistent Cash Burn Outpacing Earnings

As reported in financial statements, MODD's operating cash flow consistently tracks net losses, with the OCF/NI ratio fluctuating between 0.69 and 0.97, indicating that the company's cash outflows are fundamentally tied to its ongoing operational losses rather than significant non-cash accruals or working capital adjustments.

The tight correlation between net income and operating cash flow suggests that the company lacks the non-cash cushions often found in more mature entities. Investors should monitor this relationship, as the absence of meaningful accrual-based divergence implies that every dollar of loss is effectively a dollar of cash consumed.

Escalating Free Cash Flow Deficits

Based on the provided quarterly data, the company's free cash flow trajectory has deteriorated from a $3.6 million deficit in 2024Q2 to an $8.4 million outflow by 2026Q3, reflecting an accelerating cash burn as the firm intensifies its pre-commercial development and infrastructure spending.

The widening FCF gap highlights the increasing financial pressure on the company as it approaches critical regulatory milestones. This trend suggests that the cost of maintaining the current development pace is rising, which may necessitate external funding sooner than previously anticipated by the market.

Rising Capital Intensity During Development

According to recent SEC filings, MODD's quarterly capital expenditures have trended upward, peaking at $1.2 million in 2026Q3, which underscores the company's transition toward building the manufacturing and testing infrastructure required to support a potential commercial launch of its modular insulin delivery platform.

This increase in capital intensity is a logical, albeit expensive, step for a pre-revenue medical device firm. Analysts should evaluate whether these investments in property and equipment will provide the necessary manufacturing yields to achieve future gross margin targets once the product reaches the market.

SBC Usage Masks Operational Reality

As indicated by historical data, the company has increasingly utilized stock-based compensation, which reached $813,000 in 2026Q2, serving as a critical non-cash lever to preserve limited cash reserves while simultaneously creating potential future dilution for shareholders during this high-risk pre-revenue development phase.

While SBC is a standard tool for talent retention in early-stage firms, its reliance suggests that the company is actively managing its cash runway by substituting equity for cash compensation. Investors should remain cautious, as this practice may obscure the true cost of operations and lead to significant equity dilution upon commercialization.

MODD — Frequently Asked Questions

Quick answers to the most common questions about buying MODD stock.

How much cash does Modular Medical, Inc. (MODD) generate from operations?

Modular Medical, Inc. (MODD) generated $-15.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Modular Medical, Inc.'s free cash flow?

Modular Medical, Inc. (MODD) reported negative free cash flow of $18.2M in 2025, indicating capital requirements exceeded cash from operations.

What is Modular Medical, Inc.'s capital expenditure (CapEx)?

Modular Medical, Inc. (MODD) spent $2.5M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.